BIO
Bio-Rad Laboratories Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$262.80
+0.98 ▲ +0.37%
🌙 3월 13일 6:21 PM ET (한국 3/14 07:21)
$262.80
+0.00 +0.00%
| Index | - | P/E | 9.41 | EPS (ttm) | 27.92 | Insider Own | 32.97% | Shs Outstand | 0.02B | Perf Week | -2.61% |
| Market Cap | 7.10B | Forward P/E | 22.85 | EPS next Y | 12.19% | Insider Trans | -0.01% | Shs Float | 0.02B | Perf Month | -10.52% |
| Enterprise Value | 6.94B | PEG | 2.82 | EPS next Q | 1.87 | Inst Own | 71.58% | Short Float | 5.24% | Perf Quarter | -16.57% |
| Income | 0.76B | P/S | 2.75 | EPS this Y | 3.34% | Inst Trans | -1.73% | Short Ratio | 3.72 | Perf Half Y | -8.08% |
| Sales | 2.58B | P/B | 0.95 | EPS next 5Y | 8.1% | ROA | 7.62% | Short Interest | 0.95M | Perf YTD | -13.26% |
| Book/sh | 276.16 | P/C | 4.6 | EPS past 3/5Y | - -26.08% | ROE | 10.84% | 52W High | -23.41% ($343.12) | Perf Year | 7.26% |
| Cash/sh | 57.13 | P/FCF | 18.95 | Sales past 3/5Y | -2.68% 0.29% | ROIC | 8.63% | 52W Low | 24.3% ($211.43) | Perf 3Y | -46.23% |
| Dividend Est. | - | EV/EBITDA | 14.76 | EPS Y/Y TTM | 143.01% | Gross Margin | 52.01% | Volatility(W/M) | 2.85% 3.32% | Perf 5Y | -53.07% |
| Dividend TTM | - | EV/Sales | 2.69 | Sales Y/Y TTM | 0.65% | Oper. Margin | 10.25% | ATR (14) | 9 | Perf 10Y | 91.32% |
| Dividend Ex-Date | - | Quick Ratio | 4.19 | EPS Q/Q | 204.25% | Profit Margin | 29.42% | RSI (14) | 35.97 | Recom | 2 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.62 | Sales Q/Q | 3.85% | SMA20 | -3.08% ($271.15) | Beta | 1.2 | Target Price | $335 |
| Payout | - | Debt/Eq | 0.19 | Earnings | 2000000 | SMA50 | -10.25% ($292.81) | Rel Volume | 0.63 | Prev Close | $261.82 |
| Employees | 7450 | LT Debt/Eq | 0.18 | EPS/Sales Surpr. | -7.31% 0.64% | SMA200 | -7.83% ($285.13) | Avg Volume(3M) | 0.25M | Price | $262.8 |
| IPO | 1980/2/27 | Option/Short | Yes/Yes | Trades | 6441 | Volume | 161,773 | Change | 0.37% |
뉴스 로딩 중...